fda status of bpc-157 2024 When will the reclassify to Category 1? Odds & Predictions fda warning bpc-157 2023 2024
Description
Effects on intestinal epithelial barrier integrity, mucin expression, and gut motility have all been documented
Goal: Support appetite regulation and weight management by mimicking amylins satiety signalling [1] [3]
FEBS Open Bio 16, 382396
Well, while volume 1 was promising, I found that the following 3 volumes did not quite live up to that promise
I hope you find a good solution
Dipcin et al
